TotalMarketCap

Alnylam Pharmaceuticals

ALNYNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$21.021 B

$156.95 -2.57%

Close of 6 Nov 2026

As of 6 Nov 2026, Alnylam Pharmaceuticals (ALNY) has a market capitalization of $21.0B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$3.71B

#812 by revenue

Earnings

$313.7M

#813 by earnings

Shares outstanding

133,937,576

Latest filing cover page

P/E ratio

67.0

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #23InsmedINSM$23.9B
  2. #24ViatrisVTRS$21.8B
  3. #25Alnylam PharmaceuticalsALNY$21.0B
  4. #26Ascendis Pharma A/SASND$16.7B
  5. #27Jazz PharmaceuticalsJAZZ$14.6B

What if Alnylam Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$210,821.15

Per share 1,343× higher

Bitcoin $1.53T

$11,407.17

Per share 72.7× higher

Apple $5.02T

$37,448.66

Per share 239× higher

Or at a round number

$50.0B$100.0B$200.0B$500.0B

Where these numbers come from

Share counts and financials for Alnylam Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.